Search
-
News
Memorial Sloan Kettering Cancer Center (MSK) is partnering with DigitasLBi and Phase2 to help expand MSK's digital reach.
… Thursday, June 19, 2014 Memorial Sloan Kettering Cancer Center (MSK) today announced the appointment of DigitasLBi as its digital agency of record and Phase2 as its Drupal technology partner. Memorial Sloan Kettering’s digital reach is significant, and the institution is viewed as one of the country’
-
News
Memorial Sloan Kettering and Quest Diagnostics announced a joint collaboration that will utilize MSK’s clinical and research insights into gene mutations associated with solid tumors.
… Sunday, June 1, 2014 Diagnostic insights into gene mutations in solid tumor cancers will aid therapy selection and prognosis for patients and advance research Memorial Sloan Kettering Cancer Center, the world’s oldest and largest private cancer center, and Quest Diagnostics (NYSE: DGX), the world’s leading
-
News
Learn about some of the most important clinical advances made at MSK in 2021.
… Wednesday, December 22, 2021 In 2021, Memorial Sloan Kettering Cancer Center doctors and scientists continued to make major discoveries that will improve the treatment of cancer. Philanthropic donations provided critical support for much of this research, allowing clinical researchers to pursue innovative
-
News
Long-awaited results of clinical trials testing targeted drugs and immunotherapy combinations were on offer at the annual American Association for Cancer Research (AACR) conference.
… Monday, April 18, 2016 Summary MSK scientists featured prominently in the opening days of the annual AACR conference, held this year in New Orleans. They presented new data from clinical trials of both targeted drugs and immunotherapies, and were recognized for their scientific accomplishments. Highlights
-
News
The David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center will be home to the largest gathering of hematologic experts ever at Memorial Sloan Kettering Cancer Center (MSK), including specialists in blood and marrow stem cell transplants, chimeric antigen receptor T cell therapy, lymphoma, leukemia, multiple myeloma, and nonmalignant blood disorders.
… Tuesday, December 10, 2019 The David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center will be home to the largest gathering of hematologic experts ever at Memorial Sloan Kettering Cancer Center (MSK), including specialists in blood and marrow stem cell transplants, chimeric antigen
-
News
The 2023 GSK Chairman’s Prize recognizes Chi Nguyen for research on gut health.
… Tuesday, August 15, 2023 Chi Nguyen , a PhD student attending the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) , has been awarded the 2023 Chairman’s Prize. The competitive award is presented annually and was established by GSK’s Board of Trustees Chair Emeritus Louis V. Gerstner
-
News
New data from researchers at Memorial Sloan Kettering Cancer Center (MSK) revealed the effects of Medicaid expansion on cancer death rates on a national scale.
… Wednesday, May 13, 2020 New data from researchers at Memorial Sloan Kettering Cancer Center (MSK) revealed the effects of Medicaid expansion on cancer death rates on a national scale. The landmark study found that states that adopted Medicaid expansion following the passage of the Affordable Care Act
-
MSK News
MSK investigators are leading the way with approaches so bold they are like the difference between "a snapshot and a movie."
… Friday, April 1, 2022 VIDEO | 00:25 A Developing Mouse Embryo This movie from the Kat Hadjantonakis lab shows an 11-day-old mouse embryo with its internal organs labeled in different fluorescence. The video was prepared by postdoc Evan Bardot. Video Details To study a complex ecosystem, researchers often
-
News
Experts at MSK’s Center for Young Onset Colorectal and Gastrointestinal Cancer are devoted to creating the best treatment plan for you and your family.
… Thursday, March 25, 2021 Kellee Strong clearly remembers her first thought when a local doctor broke the news that Kellee had cancer, and it had spread to several organs: “I’m not even going to see my kids graduate from high school.” At age 42, she was enjoying a full life, with a career in the court
-
NewsSKI Study Sheds Light on How a Natural Defense Against Viruses Can Lead to Mutations in Cancer Cells
A protein in the body that protects against viruses can also cause cancer-related mutations.
… Wednesday, July 20, 2022 The body deploys many weapons to defend against internal and external threats. One tactic used by cells involves a group of proteins called APOBEC3 enzymes. These enzymes can disable viruses by disrupting the invaders’ genetic material. They also protect against certain genetic